Insulin Resistance Increases Risk of Colorectal Adenomas

This article originally appeared here.
Insulin Resistance Increases Risk of Colorectal Adenomas
Insulin Resistance Increases Risk of Colorectal Adenomas

(HealthDay News) -- Insulin resistance (IR) and central obesity, as measured by waist to hip ratio (WHR), are associated with a significantly increased risk of colorectal adenomas, especially in men, according to a study published in the April 1 issue of Cancer.

To investigate the association between homeostasis model assessment (HOMA)-IR and central obesity with the risk of colorectal adenoma, Ana Patricia Ortiz, M.P.H., Ph.D., of the University of Puerto Rico Comprehensive Cancer Center in San Juan, and associates prospectively collected data on lifestyle risk factors and fasting blood samples from 1,222 participants undergoing screening colonoscopies. Of the participants, 320 had incident adenomas and 902 did not.

The researchers found that, of the 1,093 participants who reported no antidiabetic medication use, those in the top quartiles of WHR and HOMA-IR were significantly more likely to have adenomas compared with those in the bottom quartiles (odds ratio [OR], 2.18 and 1.63, respectively). There was a significant interaction between HOMA-IR and gender (Pinteraction = 0.04), with the correlation predominantly limited to men. Men in the top tertile of HOMA-IR were significantly more likely to have adenomas compared with those in the bottom tertile (OR, 2.11).

"Results from our screening colonoscopy-based incident cross-sectional study of adenoma support the hypothesis that IR and central obesity promote the development of early colorectal neoplasia," the authors write. "Our study highlights the fact that therapeutics or chemoprevention targeting IR may represent a novel avenue for colorectal cancer prevention."

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs